메뉴 건너뛰기




Volumn 95, Issue 1, 2004, Pages 120-126

High-risk endometrial cancer subgroups: Candidates for target-based adjuvant therapy

Author keywords

Endometrial cancer; Hematogenous; Lymphatic; Peritoneal; Recurrence; Therapy

Indexed keywords

ADULT; AGED; ALGORITHM; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MYOMETRIUM; PERITONEUM CANCER; POPULATION; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RECURRENCE RISK; REGRESSION ANALYSIS; STANDARD; STROMA; UTERINE CERVIX;

EID: 4644291337     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.06.042     Document Type: Conference Paper
Times cited : (94)

References (26)
  • 3
    • 0036921635 scopus 로고    scopus 로고
    • Surgical stage I endometrial cancer: Predictors of distant failure and death
    • A. Mariani, M.J. Webb, G.L. Keeney, T.G. Lesnik, and K.C. Podratz Surgical stage I endometrial cancer: predictors of distant failure and death Gynecol. Oncol. 87 2002 274 280 (10.1006/gyno.2002.6836)
    • (2002) Gynecol. Oncol. , vol.87 , pp. 274-280
    • Mariani, A.1    Webb, M.J.2    Keeney, G.L.3    Lesnik, T.G.4    Podratz, K.C.5
  • 9
    • 0028362722 scopus 로고
    • The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer
    • P. Elliott, D. Green, A. Coates, M. Krieger, P. Russell, and M. Coppleson The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer Int. J. Gynecol. Cancer 4 1994 84 93
    • (1994) Int. J. Gynecol. Cancer , vol.4 , pp. 84-93
    • Elliott, P.1    Green, D.2    Coates, A.3    Krieger, M.4    Russell, P.5    Coppleson, M.6
  • 11
    • 0344626922 scopus 로고    scopus 로고
    • Survival after relapse in patients with endometrial cancer: Results from a randomized trial
    • for the PORTEC Study Group C.L.
    • C.L. Creutzberg for the PORTEC Study Group Survival after relapse in patients with endometrial cancer: results from a randomized trial Gynecol. Oncol. 89 2003 201 209 (10.1016/S0090-8258(03)00126-4)
    • (2003) Gynecol. Oncol. , vol.89 , pp. 201-209
    • Creutzberg1
  • 13
    • 0026060964 scopus 로고
    • Relationship between surgicalâ€"pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study
    • C.P. Morrow, B.N. Bundy, R.J. Kurman, W.T. Creasman, P. Heller, and H.D. Homesley Relationship between surgicalâ€"pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol. Oncol. 40 1991 55 65
    • (1991) Gynecol. Oncol. , vol.40 , pp. 55-65
    • Morrow, C.P.1    Bundy, B.N.2    Kurman, R.J.3    Creasman, W.T.4    Heller, P.5    Homesley, H.D.6
  • 14
  • 15
    • 0037468117 scopus 로고    scopus 로고
    • Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus
    • T. Kasamatsu, T. Onda, N. Katsumata, M. Sawada, T. Yamada, and R. Tsunematsu Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus Br. J. Cancer 88 2003 245 250
    • (2003) Br. J. Cancer , vol.88 , pp. 245-250
    • Kasamatsu, T.1    Onda, T.2    Katsumata, N.3    Sawada, M.4    Yamada, T.5    Tsunematsu, R.6
  • 16
    • 0036443876 scopus 로고    scopus 로고
    • Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?
    • A. Ayhan, C. Taskiran, C. Celik, I. Guney, K. Yuce, and E. Ozyar Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer? Gynecol. Oncol. 86 2002 259 263 (10.1006/gyno.2002.6630)
    • (2002) Gynecol. Oncol. , vol.86 , pp. 259-263
    • Ayhan, A.1    Taskiran, C.2    Celik, C.3    Guney, I.4    Yuce, K.5    Ozyar, E.6
  • 19
    • 0036181128 scopus 로고    scopus 로고
    • Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer
    • L. Elit, and H. Hirte Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer Curr. Opin. Obstet. Gynecol. 14 2002 67 73
    • (2002) Curr. Opin. Obstet. Gynecol. , vol.14 , pp. 67-73
    • Elit, L.1    Hirte, H.2
  • 21
    • 0034012367 scopus 로고    scopus 로고
    • Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer
    • A. Mariani, M.J. Webb, L. Galli, and K.C. Podratz Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer Gynecol. Oncol. 76 2000 348 356 (10.1006/gyno.1999.5688)
    • (2000) Gynecol. Oncol. , vol.76 , pp. 348-356
    • Mariani, A.1    Webb, M.J.2    Galli, L.3    Podratz, K.C.4
  • 22
    • 18144432776 scopus 로고    scopus 로고
    • Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial
    • for the PORTEC Study Group C.L.
    • C.L. Creutzberg for the PORTEC Study Group Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial Lancet 355 2000 1404 1411
    • (2000) Lancet , vol.355 , pp. 1404-1411
    • Creutzberg1
  • 23
    • 8244262046 scopus 로고    scopus 로고
    • Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy
    • T. Onda, H. Yoshikawa, K. Mizutani, M. Mishima, H. Yokota, and H. Nagano Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy Br. J. Cancer 75 1997 1836 1841
    • (1997) Br. J. Cancer , vol.75 , pp. 1836-1841
    • Onda, T.1    Yoshikawa, H.2    Mizutani, K.3    Mishima, M.4    Yokota, H.5    Nagano, H.6
  • 25
    • 0023711776 scopus 로고
    • Results of whole abdominopelvic irradiation with nodal boost for patients with endometrial cancer at high risk of failure in the peritoneal cavity: A prospective clinical trial at the Mayo Clinic
    • A. Martinez, K. Podratz, M. Schray, and G. Malkasian Results of whole abdominopelvic irradiation with nodal boost for patients with endometrial cancer at high risk of failure in the peritoneal cavity: a prospective clinical trial at the Mayo Clinic Hematol./Oncol. Clin. North Am. 2 1988 431 446
    • (1988) Hematol./Oncol. Clin. North Am. , vol.2 , pp. 431-446
    • Martinez, A.1    Podratz, K.2    Schray, M.3    Malkasian, G.4
  • 26
    • 0345132902 scopus 로고    scopus 로고
    • Whole abdominal radiotherapy versus combination doxorubicin†"cisplatin chemotherapy in advanced endometrial carcinoma: A randomized phase III trial of the Gynecologic Oncology Group (abstract)
    • for the Gynecologic Oncology Group M.E.
    • M.E. Randall for the Gynecologic Oncology Group Whole abdominal radiotherapy versus combination doxorubicinâ€"cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group (abstract) Prog. Proc. Am. Soc. Clin. Oncol. 22 2003 2
    • (2003) Prog. Proc. Am. Soc. Clin. Oncol. , vol.22 , pp. 2
    • Randall1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.